Study: Direct-to-Consumer Telehealth Docs Prescribing "Inappropriately" | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study: Direct-to-Consumer Telehealth Docs Prescribing "Inappropriately"

May 27, 2015
by Gabriel Perna
| Reprints
Providers treating patients through direct-to-consumer telehealth services were more likely to prescribe costly, antibiotic resistance medication than in-person doctors, according to the recent findings of a research study.
 
The RAND Corporation, a Santa Monica, Calif.-based nonprofit organization, compared  antibiotic prescribing rates for acute respiratory infection between Teladoc, a direct-to-consumer telemedicine company, and physician offices.
 
What they found was physicians in both settings were prescribing the same amount of antibiotics, however, direct-to-consumer telehealth doctors had higher rates of "inappropriate" prescribing for bronchitis and other respiratory conditions. 
 
Specifically, the telehealth doctors were prescribing broad-spectrum antibiotics at a higher rate. Ninety-four percent of Teladoc physicians prescribed broad-spectrum antibiotics for bronchitis, compared to 76 percent of in-person physicians. For sinusitis, it was a 85 percent of Teladoc physicians and 50 percent of in-person physicians. Broad-spectrum antibiotic prescriptions are costlier and contribute to antibiotic resistance, the researchers say. They expressed concern that the higher use of broad-spectrum antibiotics by the telemedicine doctors may be a result of direct-to-consumer companies practicing conservatively, based upon limited diagnostic information about their patients.
 
“The pattern of treatment offered to patients who saw a physician face-to-face versus those who spoke with a physician on the telephone was not substantially different,” states Lori Usher-Pines, the study’s lead author and a policy researcher at RAND, a nonprofit research organization. “However, we found the antibiotics prescribed during telemedicine ‘visits’ raised some specific quality concerns that require further attention.”
 
Direct-to-consumer telehealth companies are on the rise, thanks to the convenience they offer and a shortage of primary-care physicians. However, RAND researchers are concerned with the lack of studies that been conducted on the effectiveness of the care they provide.
 
The research was published in JAMA Internal Medicine. 
 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.